BMG PHARMA   Report issue

For profit Phase 3
Founded: Milan Italy (2006)

Organization Overview

First Clinical Trial
2020
NCT04438434
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

BMG PHARMA

Active Ingredients

Drugs in Phase 3 Trials (3)

chlorhexidine (hibitane) (2 trials)

hyaluronic acid (2 trials)

hydrogen peroxide (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gingival Hemorrhage (Phase 3)

Hemorrhage (Phase 3)

Periodontal Pocket (Phase 3)

Periodontitis (Phase 3)

Surgical Wound (Phase 3)

Tooth, Impacted (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3